Are you now suggesting the decline post SPP was now due to an ex director selling down? The last 2 years you’ve been silent on that but blamed the total biotech sector being down.
I’d suggest the mess of not pulling off the $4.50 raise was a lack of experience and foresight on your behalf in hoping clinicians would do one thing based on what they told you, yet commercially did another. That’s the way the world works.
Again, good intentions, but inexperience got us here.
Ann: Application for quotation of securities - RAC, page-20
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.045(2.81%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.70 | $1.52 | $317.7K | 193.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22586 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 750 | 1 |
View Market Depth
| Last trade - 15.57pm 28/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |